An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: The OPTIMA-2 randomized controlled trial
Authors:
- 1 April 2021
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 234, 42-50
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca
This publication has 18 references indexed in Scilit:
- Early or late intervention in high-risk non-ST-elevation acute coronary syndromes: results of the ELISA-3 trialEuroIntervention, 2013
- Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial)European Heart Journal, 2011
- Standardized Bleeding Definitions for Cardiovascular Clinical TrialsCirculation, 2011
- Pharmacokinetics, pharmacodynamics, safety and tolerability of multiple ascending doses of ticagrelor in healthy volunteersBritish Journal of Clinical Pharmacology, 2010
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2009
- Immediate vs Delayed Intervention for Acute Coronary SyndromesJAMA, 2009
- Early versus Delayed Invasive Intervention in Acute Coronary SyndromesNew England Journal of Medicine, 2009
- Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromesHeart, 2008
- Utility of Cardiac Biomarkers in Predicting Infarct Size, Left Ventricular Function, and Clinical Outcome After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial InfarctionJACC: Cardiovascular Interventions, 2008
- Early and Late Effects of Clopidogrel in Patients With Acute Coronary SyndromesCirculation, 2003